Celldex Therapeutics Inc.

+1.46 (+4.16%)
7:57:08 PM EDT: $37.29 +0.73 (+2.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.73B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.41 Million
Adjusted EPS-$0.62
See more estimates
10-Day MA$39.47
50-Day MA$43.71
200-Day MA$35.52
See more pivots

Celldex Therapeutics Inc. Stock, NASDAQ:CLDX

Perryville III Building, 53 Frontage Road, Hampton, New Jersey 08827
United States of America
Phone: +1.908.454.7120
Number of Employees: 148


Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.